| Followers | 1106 |
| Posts | 279775 |
| Boards Moderated | 10 |
| Alias Born | 03/18/2011 |
Monday, April 23, 2012 7:53:22 AM
Meredith Corporation (Meredith) is a media and marketing company. The Company is engaged in magazine publishing and related brand licensing, television broadcasting, integrated marketing, interactive media, and video production related operations. The Company operates two business segments: national media and local media. The national media segment includes magazine publishing, brand licensing, integrated marketing, interactive media, database-related activities and other related operations. The local media segment consists primarily of the operations of network-affiliated television stations, related interactive media operations and video production related operations. In July 2010, it completed its acquisition of The Hyperfactory. During the fiscal year ended June 30, 2011 (fiscal 2011), Meredith relaunched Websites, including BHG.com and Recipe.com. In January 2012, it acquired FamilyFun from Disney Publishing Worldwide. In March 2012, it acquired Allrecipes.com, digital food brand.
http://www.google.com/finance?q=MDP
http://www.google.com/finance?q=MDP
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent MDP News
- Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation • Newsfile • 04/15/2026 09:30:00 PM
- Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection • Newsfile • 02/11/2026 10:30:00 PM
- Medexus Schedules Third Fiscal Quarter 2026 Conference Call • Newsfile • 02/03/2026 10:30:00 PM
- Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares • Newsfile • 11/20/2025 12:30:00 PM
- Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares • Newsfile • 11/17/2025 01:30:00 PM
- Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection • Newsfile • 11/12/2025 11:06:00 PM
- Medexus Schedules Second Fiscal Quarter 2026 Conference Call • Newsfile • 11/04/2025 10:30:00 PM
- Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors • Newsfile • 09/25/2025 09:30:00 PM
